Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 67
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT04548999 GAVOTTE — A Study to Evaluate the Efficacy, Safety and Pharmacokinetics… |
Ocrelizumab | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Argentina, Belgium, Brazil, Bulgaria, … | 2020-12-03 → 2027-09-08 | Ouvrir |
| NCT01412333 A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in… |
Interferon beta-1a | SEP | Phase 3 | COMPLETED | En attente / non publié | German University in Cairo | United States, Argentina, Belarus, Belgium, Bosnia an… | 2011-09-20 → 2022-12-30 | Ouvrir |
| NCT03589105 PRO-MSACTIVE — A Study to Provide Complementary Efficacy, Safety and Pa… |
Ocrelizumab 300 mg | SEP | Phase 4 | COMPLETED | En attente / non publié | Hoffmann-La Roche | France · Centre hospitalier Andre Mignot; Neurologie,… | 2018-08-06 → 2021-02-15 | Ouvrir |
| NCT05762003 CPE — Czech Pharmaco-epidemiological Study on Disease Modifying Drugs |
interferons, glatiramer acetate, … | SEP | À vérifier | COMPLETED | En attente / non publié | IMPULS Endowment Fund | Czechia · IMPULS Endowment Fund, Prague, Czechia | 2019-01-01 → 2021-12-31 | Ouvrir |
| NCT03853746 Short-term B-cell Depletion in Relapsing Multiple Sclerosis |
Ocrelizumab | SEP | Phase 4 | COMPLETED | En attente / non publié | Hoffmann-La Roche | United States · Johns Hopkins University, Baltimore, … | 2019-04-01 → 2024-07-01 | Ouvrir |
| NCT03157830 OCTAVE — Evaluating the Efficacy and Safety of Transitioning Patients F… |
OCTAVE — Evaluating the Efficacy … | SEP | À vérifier | COMPLETED | En attente / non publié | Providence Health & Services | United States · Kadlec Neuroscience Center, Richland,… | 2017-06-01 → 2022-06-06 | Ouvrir |
| NCT04838015 SEP-RR — Retrospective Study on Registry Data to Evaluate the Impact of… |
SEP-RR — Retrospective Study on R… | SEP | À vérifier | UNKNOWN | En attente / non publié | University Hospital, Strasbourg, … | France · Hautepierre Clinical Investigation Center - … | 2020-11-13 → 2021-11-13 | Ouvrir |
| NCT03873389 Ocrelizumab Effects on the Metabolome in MS |
Ocrelizumab | SEP | À vérifier | COMPLETED | En attente / non publié | Hoffmann-La Roche | United States · Johns Hopkins University, Baltimore, … | 2019-06-12 → 2023-12-05 | Ouvrir |
| NCT04478591 WOC — The Wearing-off Phenomenon of Ocrelizumab in Patients With Multip… |
WOC — The Wearing-off Phenomenon … | SEP | À vérifier | COMPLETED | En attente / non publié | Amsterdam UMC, location VUmc | Netherlands · Amsterdam UMC, location VUmc, Amsterdam… | 2020-05-12 → 2021-05-01 | Ouvrir |
| NCT04676555 TIMIOS — Time and Motion Study for Ocrelizumab and Ofatumumab Administr… |
Ocrelizumab | SEP | À vérifier | COMPLETED | En attente / non publié | Hoffmann-La Roche | United States, Australia · Novartis Investigative Sit… | 2021-05-11 → 2021-10-21 | Ouvrir |
| NCT05131984 Ocrelizumab Access by Socio-Economic Status |
Ocrelizumab | SEP | À vérifier | COMPLETED | En attente / non publié | Hoffmann-La Roche | United States · Brigham and Women's Hospital, Boston,… | 2021-11-18 → 2023-07-01 | Ouvrir |
| NCT05528666 Risk Perception in Multiple Sclerosis |
Risk Perception in Multiple Scler… | SEP | À vérifier | COMPLETED | En attente / non publié | Novartis Pharmaceuticals | United States · Novartis Investigative Site, East Han… | 2021-09-09 → 2021-09-17 | Ouvrir |
| NCT05210621 CONSONANCE EX — LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELI… |
Ocrelizumab | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | France · Amiens University Hospital, Amiens, France |… | 2022-03-08 → 2029-02-24 | Ouvrir |
| NCT07207148 People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agoni… |
GLP-1 | SEP | À vérifier | RECRUITING | En attente / non publié | Northwestern University | United States · Northwestern Memorial Hospital, Chica… | 2025-11-15 → 2028-08-31 | Ouvrir |
| NCT05974839 Effect of Ocrelizumab on Cortical Lesion Accumulation in Patients With … |
Effect of Ocrelizumab on Cortical… | SEP | À vérifier | COMPLETED | En attente / non publié | State University of New York at B… | United States · Buffalo Neuroimaging Analysis Center,… | 2023-10-01 → 2024-02-28 | Ouvrir |
| NCT05974852 ORATORIO-CP — Effect of Ocrelizumab on Choroid Plexus Changes in Patien… |
ORATORIO-CP — Effect of Ocrelizum… | SEP | À vérifier | COMPLETED | En attente / non publié | State University of New York at B… | United States · Buffalo Neuroimaging Analysis Center,… | 2023-10-01 → 2023-12-30 | Ouvrir |
| NCT01194570 ORATORIO — A Study of Ocrelizumab in Participants With Primary Progress… |
Ocrelizumab | SEP | Phase 3 | COMPLETED | En attente / non publié | Hoffmann-La Roche | United States, Australia, Austria, Belgium, Brazil, B… | 2011-03-02 → 2022-12-31 | Ouvrir |